Cargando…
Prognostic Value of the Lymphocyte‐to‐Monocyte Ratio in Patients with Parotid Gland Carcinoma
OBJECTIVE: Previous studies have evaluated various markers as prognostic predictors in patients with many types of cancers. However, the influence of such factors on the outcomes of patients with parotid gland carcinoma (PGC) is unknown. This study investigated the roles of alternative markers in th...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891395/ https://www.ncbi.nlm.nih.gov/pubmed/32673437 http://dx.doi.org/10.1002/lary.28934 |
_version_ | 1783652690027347968 |
---|---|
author | Mikoshiba, Takuya Ozawa, Hiroyuki Watanabe, Yoshihiro Sekimizu, Mariko Saito, Shin Yoshihama, Keisuke Nakamura, Shintaro Imanishi, Yorihisa Kameyama, Kaori Ogawa, Kaoru |
author_facet | Mikoshiba, Takuya Ozawa, Hiroyuki Watanabe, Yoshihiro Sekimizu, Mariko Saito, Shin Yoshihama, Keisuke Nakamura, Shintaro Imanishi, Yorihisa Kameyama, Kaori Ogawa, Kaoru |
author_sort | Mikoshiba, Takuya |
collection | PubMed |
description | OBJECTIVE: Previous studies have evaluated various markers as prognostic predictors in patients with many types of cancers. However, the influence of such factors on the outcomes of patients with parotid gland carcinoma (PGC) is unknown. This study investigated the roles of alternative markers in the prognoses of patients with PGC. METHODS: Overall, 101 patients who underwent curative treatment for PGC were retrospectively evaluated, and their 5‐year overall and disease‐free survival rates were calculated. The prognostic values of clinical and pathologic factors were determined. RESULTS: The 5‐year overall and disease‐free survival rates were 73.1% and 62.8%, respectively. Multivariate analysis revealed that a low lymphocyte‐to‐monocyte ratio (LMR), high T classification, high N classification, and perineural invasion were independent predictors of poor prognosis. CONCLUSIONS: Thus, we identified LMR as an independent prognostic factor for patients with PGC. Patients with low LMRs who are amenable to treatment may require adjuvant treatment to improve their prognoses. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:E864–E869, 2021 |
format | Online Article Text |
id | pubmed-7891395 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78913952021-03-02 Prognostic Value of the Lymphocyte‐to‐Monocyte Ratio in Patients with Parotid Gland Carcinoma Mikoshiba, Takuya Ozawa, Hiroyuki Watanabe, Yoshihiro Sekimizu, Mariko Saito, Shin Yoshihama, Keisuke Nakamura, Shintaro Imanishi, Yorihisa Kameyama, Kaori Ogawa, Kaoru Laryngoscope Head and Neck OBJECTIVE: Previous studies have evaluated various markers as prognostic predictors in patients with many types of cancers. However, the influence of such factors on the outcomes of patients with parotid gland carcinoma (PGC) is unknown. This study investigated the roles of alternative markers in the prognoses of patients with PGC. METHODS: Overall, 101 patients who underwent curative treatment for PGC were retrospectively evaluated, and their 5‐year overall and disease‐free survival rates were calculated. The prognostic values of clinical and pathologic factors were determined. RESULTS: The 5‐year overall and disease‐free survival rates were 73.1% and 62.8%, respectively. Multivariate analysis revealed that a low lymphocyte‐to‐monocyte ratio (LMR), high T classification, high N classification, and perineural invasion were independent predictors of poor prognosis. CONCLUSIONS: Thus, we identified LMR as an independent prognostic factor for patients with PGC. Patients with low LMRs who are amenable to treatment may require adjuvant treatment to improve their prognoses. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:E864–E869, 2021 John Wiley & Sons, Inc. 2020-07-16 2021-03 /pmc/articles/PMC7891395/ /pubmed/32673437 http://dx.doi.org/10.1002/lary.28934 Text en © 2020 The Authors. The Laryngoscope published by Wiley Periodicals LLC. on behalf of The American Laryngological, Rhinological and Otological Society, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Head and Neck Mikoshiba, Takuya Ozawa, Hiroyuki Watanabe, Yoshihiro Sekimizu, Mariko Saito, Shin Yoshihama, Keisuke Nakamura, Shintaro Imanishi, Yorihisa Kameyama, Kaori Ogawa, Kaoru Prognostic Value of the Lymphocyte‐to‐Monocyte Ratio in Patients with Parotid Gland Carcinoma |
title | Prognostic Value of the Lymphocyte‐to‐Monocyte Ratio in Patients with Parotid Gland Carcinoma |
title_full | Prognostic Value of the Lymphocyte‐to‐Monocyte Ratio in Patients with Parotid Gland Carcinoma |
title_fullStr | Prognostic Value of the Lymphocyte‐to‐Monocyte Ratio in Patients with Parotid Gland Carcinoma |
title_full_unstemmed | Prognostic Value of the Lymphocyte‐to‐Monocyte Ratio in Patients with Parotid Gland Carcinoma |
title_short | Prognostic Value of the Lymphocyte‐to‐Monocyte Ratio in Patients with Parotid Gland Carcinoma |
title_sort | prognostic value of the lymphocyte‐to‐monocyte ratio in patients with parotid gland carcinoma |
topic | Head and Neck |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891395/ https://www.ncbi.nlm.nih.gov/pubmed/32673437 http://dx.doi.org/10.1002/lary.28934 |
work_keys_str_mv | AT mikoshibatakuya prognosticvalueofthelymphocytetomonocyteratioinpatientswithparotidglandcarcinoma AT ozawahiroyuki prognosticvalueofthelymphocytetomonocyteratioinpatientswithparotidglandcarcinoma AT watanabeyoshihiro prognosticvalueofthelymphocytetomonocyteratioinpatientswithparotidglandcarcinoma AT sekimizumariko prognosticvalueofthelymphocytetomonocyteratioinpatientswithparotidglandcarcinoma AT saitoshin prognosticvalueofthelymphocytetomonocyteratioinpatientswithparotidglandcarcinoma AT yoshihamakeisuke prognosticvalueofthelymphocytetomonocyteratioinpatientswithparotidglandcarcinoma AT nakamurashintaro prognosticvalueofthelymphocytetomonocyteratioinpatientswithparotidglandcarcinoma AT imanishiyorihisa prognosticvalueofthelymphocytetomonocyteratioinpatientswithparotidglandcarcinoma AT kameyamakaori prognosticvalueofthelymphocytetomonocyteratioinpatientswithparotidglandcarcinoma AT ogawakaoru prognosticvalueofthelymphocytetomonocyteratioinpatientswithparotidglandcarcinoma |